| Year | Number | |||
| 2025 | 109 | Halegoua-DeMarzio D, Stolz A, Avula B, Khan I, Navarro V. Meeting Report: Herbal and Dietary Supplement Safety Surveillance Summit. Drug Safety. 2025/08/09 2025;doi:10.1007/s40264-025-01589-8. PMID: 40783601. PMCID:
|
||
| 2025 | 108 | Rahnama-Moghadam S, Arora N, Vuppalanchi R, Li YJ, Gu J, Barnhart H, Phillips E, Chalasani N; Drug Induced Liver Injury Network. DRESS Syndrome in Patients With Drug-Induced Liver Injury: Characteristics and HLA Risk Factors. Am J Gastroenterol. 2025 Jun 12. doi: 10.14309/ajg.0000000000003590. Online ahead of print. PMID: 40504263. PMCID:
|
||
| 2025 | 107 | Vuppalanchi R, Li YJ, Rockey DC, Halegoua-DeMarzio D, Fontana RJ, Bonkovsky HL, Koh C, Odin J, Barnhart H, Hoofnagle JH; Drug‐Induced Liver Injury Network (DILIN). Clinical and Genetic Associations in Cephalosporin-Induced Liver Injury: Insights From the Drug-Induced Liver Injury Network. Aliment Pharmacol Ther. 2025 Jul 20. doi: 10.1111/apt.70284. Epub ahead of print. PMID: 40685563. PMCID:
|
||
| 2025 | 106 | Ahmad J, Dellinger A, Nicoletti P, Barnhart HX, Ghabril M, Fontana RJ, Navarro V, Choi G, Hayashi PH, Gu J, Kleiner D; for the; Drug-Induced Liver Injury Network. Clinical and HLA Associations of Fluoroquinolone-Induced Liver Injury: Results From the Drug-Induced Liver Injury Network. Am J Gastroenterol. 2025 Apr 10:10.14309/ajg.0000000000003457. doi: 10.14309/ajg.0000000000003457. Epub ahead of print. PMID: 40207808; PMCID: PMC12353811 (available on 2026-04-10)
|
||
| 2025 | 105 | Church RJ, Anchang B, Bennett BD, Bushel PR, Watkins PB. Blood Toxicogenomics Reveals Potential Biomarkers for Management of Idiosyncratic Drug-Induced Liver Injury. Front Genet. 2025. 16:1524433.
doi: 10.3389/fgene.2025.1524433. PMID: 40201567. Free PMC article.
|
||
| 2025 | 104 | Ahmad J, Li Y-J, Phillips E, Dellinger A, Hayashi PH, Chalasani N, Fontana RJ, Kleiner DE, Barnhart HX, Hoofnagle JH. Liver Injury due to Intravenous Methylprednisolone in the Drug-Induced Liver Injury Network. Liver Int. 2025 Feb;45(2):e16242. doi: 10.1111/liv.16242. PMID: 39803998 PMCID: PMC11790010 (available on 2026-02-01)
|
||
| 2024 | 103 | Gopalakrishna H, Ghabril M, Gu J, Li Y-J, Fontana R, Kleiner D, Koh C, Chalasani N. Drug-Induced Liver Injury due to Medications for Alcohol Use Disorder: Insights from the DILIN Prospective Study. J Addict Med. 2024 Dec 9. doi: 10.1097/ADM.0000000000001421. Epub ahead of print. PMID: 39651750. PMCID: PMC12133418
|
||
| 2024 | 102 | Barritt AS, Hayashi PH, Stolz A, Barnhart H, Hoofnagle JH. Refinement of Hy’s Law using the Drug-Induced Liver Injury Network Database. Am J Gastroenterol. 2024 Oct 18. doi: 10.14309/ajg.0000000000003145. Online ahead of print. PMID: 39422332. PMCID: PMC12087471
|
||
| 2024 | 101 | Chen V, Rockey D, Bjornsson E, Barnhart H, Hoofnagle JH. Incidence of Idiosyncratic Drug-Induced Liver Injury Caused by Prescription Drugs. Drug Safety. 2025 Feb;48(2):151-160. doi: 10.1007/s40264-024-01486-6. Epub 2024 Sep 24. PMID: 39317916 PMCID: PMC11785493 (available on 2026-02-01)
|
||
| 2024 | 100 | Halegoua-DeMarzio D, Navarro V, Davis A, Ahmad J, Avula B, Barnhart H, Barritt S, Bonkovsky H, Chen V, Choi G, Fontana R, Ghabril M, Khan I, Koh C, Odin J, Rockey D, Rossi S, Rostami H, Serrano J, Sherker A, Stolz A, Tillmann H, Vuppalanchi R. Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury. Drug Safety. 2025 Feb;48(2):143-150. doi: 10.1007/s40264-024-01484-8. Epub 2024 Oct 1. PMID: 39354283 PMCID: PMC11785658
|
||
| 2024 | 99 | Fontana RJ, Li YJ, Chen V, Kleiner D, Stolz A, Odin J, Vuppalanchi R, Gu J, Dara L, Barnhart H on behalf of the Drug Induced Liver Injury Network. Genetic Variants Associated with Immune Mediated Liver Injury from Checkpoint Inhibitors. Hepatology Communications. 2024 Aug 26;8(9):e0518. doi: 10.1097/HC9.0000000000000518. PMID: 39185906 PMCID: PMC11357698
|
||
| 2024 | 98 | Conlon C, Li Y-J, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, Hayashi PH, Kleiner DE, Lee WM, Navarro V, Odin J, Phillips EJ, Stolz A, Vuppalanchi R, Halegoua-DeMarzio D. Clinical Characteristics and HLA Associations of Azithromycin-Induced Liver Injury. Aliment Pharmacol Ther. 2024 Sep;60(6):787-795. doi: 10.1111/apt.18160. Epub 2024 Jul 10. PMID: 38988034 PMCID: PMC11587661
|
||
| 2024 | 97 | Choi G, Ahmad J, Navarro V, Thung S, Khan I, Avula B, Barnhart H, Stolz A. Characterization of an Outbreak of Acute Liver Injury After Ingestion of Plant Based Food Supplement. Aliment Pharmacol Ther., 2024 Aug;60(4):479-483. doi: 10.1111/apt.18116. PMID: 38874448 PMCID: PMC11587764
|
||
| 2024 | 96 | Masood U, Venturini N, Nicoletti P, Dellinger A, Kleiner D, Bonkovsky H, Barnhart H, Vuppalanchi R, Rossi S, Odin J, Kushner T. Clinical Features and Outcomes Associated With Drug-Induced Liver Injury in Pregnancy: The US Drug-Induced Liver Injury Network Experience. Obstetrics & Gynecology, Obstet Gynecol. 2024 Jun 1;143(6):819-823. doi: 10.1097/AOG.0000000000005585. Epub 2024 Apr 16. PMID: 38626448. PMCID: PMC11098677
|
||
| 2024 | 95 | Bonkovsky HL, Ghabril M, Nicoletti P, Dellinger A, Fontana RJ, Barnhart H, Gu J, Daly AK, Aithal GP, Phillips EJ, Kleiner DE. Drug-Induced Liver Injury [DILI] ascribed to Non-steroidal Anti-inflammatory Drugs [NSAIDs] in the USA— Update with Genetic Correlations. Liver Int. 2024 Mar 7. doi: 10.1111/liv.15892. Epub ahead of print. PMID: 38451034. PMCID:PMC12009671
|
||
| 2024 | 94 | Pop A, Halegoua-DeMarzio D, Barnhart H, Kleiner D, Avigan M, Gu J, Chalasani N, Ahmad J, Fontana RJ, Lee W, Barritt AS. Amiodarone and Dronedarone Causes Liver Injury with Distinctly Different Clinical Presentations. Dig Dis Sci. 2024 Feb 28. doi: 10.1007/s10620-023-08251-2. Epub ahead of print. PMID: 38416280. PMCID: 11026178.
|
||
| 2024 | 93 | Fontana RJ. , Li Yi-Ju, Vuppalanchi R, Kleiner D, Gu J, Shroff Hersh M, Van W, Lisa B, Watkins P on behalf of the US DILIN study group. ERAP-1 and ERAP-2 variants in Liver injury following COVID-19 mRNA Vaccination: A US Multicenter Study. The American Journal of Gastroenterology 2024 Aug 1;119(8):1496-1505. PMID: 38314748 PMCID: PMC11296936
|
||
| 2024 | 92 | Nicoletti P, Dellinger A, Li Y-J, Barnhart H, Phillips E, Chalasani N. HLA-B*53:01 Is a Significant Risk Factor for Liver Injury Due to Phenytoin and Other Anti-epileptic Drugs in African Americans. The American Journal of Gastroenterology January 2024; 119(1):200-202; DOI: 10.14309/ajg.0000000000002454. PMID: 37552102. PMCID: PMC10841235
|
||
| 2023 | 91 | Asif B, Koh C, Phillips EJ, Gu J, Li Y-J, Barnhart H, Chalasani N, Fontana RJ, Hayashi PH, Navarro VJ, Hoofnagle JH. Vancomycin Induced Liver Injury, DRESS, and HLA-A*32:01. J Allergy Clin Immunol Pract. 2023 Sep 20:S2213-2198(23)01021-8. doi: 10.1016/j.jaip.2023.09.011. Epub ahead of print. PMID: 37739311.PMCID: PMC10885131
|
||
| 2023 | 90 | Barritt AS 4th, Barnhart H, Gu J, Dellinger A, Rudnick S, Bonkovsky HL; DILIN Investigators. When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network. Am J Gastroenterol. 2023 Dec 1;118(12):2301-2304. doi: 10.14309/ajg.0000000000002370. Epub ahead of print. PMID: 37311048. PMCID:10898250
|
||
| 2023 | 89 | Fontana RJ, Kleiner DE, Chalasani N, Bonkovsky HL, Gu J, Barnhart H, Li YJ, Hoofnagle JH. The Impact of Patient Age and Corticosteroid Use in Patients With Sulfonamide Hepatotoxicity. Clin Gastroenterol Hepatol. 2023 Sep 1;118(9):1566-1575; DOI: 10.14309/ajg.0000000000002232. PMID: 36848311. PMCID: PMC10511659
|
||
| 2023 | 88 | Nicoletti P, Dellinger A, Li YJ, Barnhart HX, Chalasani N, Fontana RJ, Odin JA, Serrano J, Stolz A, Etheridge AS, Innocenti F, Govaere O, Grove JI, Stephens C, Aithal GP, Andrade RJ, Bjornsson ES, Daly AK, Lucena MI, Watkins P. Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury due to Amoxicillin-Clavulanate. Gastroenterology. 2023;164(3):454-466. DOI: 10.1053/j.gastro.2022.11.036. PMID: 36496055 PMCID: PMC9974860.
|
||
| 2023 | 87 | Halegoua-DeMarzio D, Navarro V, Ahmad J, Avula B, Barnhart H, Barritt AS, Bonkovsky HL, Fontana RJ, Ghabril MS, Hoofnagle JH, Khan IA, Kleiner DE, Phillips E, Stolz A, Vuppalanchi R. Liver Injury Associated with Turmeric–a Growing Problem Ten Cases from the Drug-Induced Liver Injury Network [DILIN]. The American Journal of Medicine. 2023: 136(2): 200-206DOI: https://doi.org/10.1016/j.amjmed.2022.09.026. PMID: 36252717. PMCID: PMC9892270.
|
||
| 2023 | 86 | Chalasani N, Li YJ, Dellinger A, Navarro V, Bonkovsky H, Fontana RJ, Gu J, Barnhart H, Phillips E, Lammert C, Schwantes-An TH, Nicoletti P, Kleiner DE, Hoofnagle JH; Drug Induced Liver Injury Network. Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury. J Hepatol. 2023; 78(2):293-300. doi: 10.1016/j.jhep.2022.09.010. PMID: 36152763. PMCID: PMC9852026.
|
||
| 2022 | 85 | Ma J, Mathur K, Muldoon JL, Ghabril M, Chalasani N, Vuppalanchi R. Progressive Cholestasis and Biliary Cirrhosis After Initiating Oral Semaglutide: Report From the Drug-Induced Liver Injury Network. ACG Case Rep J. 2022 Dec 26;9(12):e00922. doi: 10.14309/crj.0000000000000922. PMID: 36600793; PMCID: PMC9794239.
|
||
| 2022 | 84 | Fontana RJ, Engle RE, Hayashi PH, Gu J, Kleiner DE, Nguyen H, Barnhart H, Hoofnagle JH, Farci P. The Incidence of Hepatitis E infection in American Patients with Suspected Drug-Induced Liver Injury Is Low and Declining: The DILIN Prospective Study. Am J Gastroenterol. 2022 Sep 1;117(9):1462-1470. PMID: 35973149 PMCID: PMC9437122
|
||
| 2022 | 83 | Devarbhavi H, Ghabril M, Barnhart H, Patil M, Raj S, Gu J, Chalasani N, Bonkovsky HL. Leflunomide-Induced Liver Injury: Differences in Characteristics and Outcomes in Indian and US Registries. Liver International. Liver Int. 2022 Jun;42(6):1323-1329. doi: 10.1111/liv.15189. PMID: 35129282 PMCID: PMC9187582
|
||
| 2022 | 82 | Ahmad J, Barnhart HX, Bonacini M, Ghabril M, Hayashi PH, Odin JA, Rockey DC, Rossi S, Serrano J, Tillmann HL, Kleiner DE. for the Drug-Induced Liver Injury Network. Value of liver biopsy in the diagnosis of drug-induced liver injury. Journal of Hepatology. 2022 May;76(5):1070-1078. https://doi.org/10.1016/j.jhep.2021.12.043. PMID: 35074471 PMCID: PMC9018618
|
||
| 2022 | 81 | Hayashi PH, Lucena MI, Fontana RJ, Bjornsson ES, Aithal GP, Barnhart H, Gonzalez Jimenez A, Yang Q, Gu J, Andrade RJ, Hoofnagle JH. A Revised Electronic Version of RUCAM for the Diagnosis of Drug Induced Liver Injury. Hepatology. 2022 Jul; 76(1): 18–31. doi: 10.1002/hep.32327. PMID: 35014066. PMCID: PMC9233102
|
||
| 2022 | 80 | Chalasani N, Bonkovsky HL, Stine JG, Gu J, Barnhart H, Jacobsen E, Björnsson E, Fontana RJ, Kleiner DE, Hoofnagle JH; Drug-Induced Liver Injury Network (DILIN) Study Investigators. Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study. J Hepatol. 2022 Apr;76(4):832-840. doi: 10.1016/j.jhep.2021.12.013. PMID: 34953957 PMCID: PMCID8944173
|
||
| 2022 | 79 | Vuppalanchi R, Bonkovsky HL, Ahmad J, Barnhart H, Durazo F, Fontana RJ, Gu J, Khan I, Kleiner DE, Koh C, Rockey DC, Phillips EJ, Li YJ, Serrano J, Stolz A, Tillmann HL, Seeff LB, Hoofnagle JH, Navarro VJ; Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver Injury. Clin Gastroenterol Hepatol. 2022 Jun;20(6):e1416-e1425. doi: 10.1016/j.cgh.2021.08.015. PMID: 34400337 PMCID: PMC9004424
|
||
| 2021 | 78 | Fontana RJ, Li YJ, Phillips E, Saeed N, Barnhart H, Kleiner D, Hoofnagle J on behalf of the Drug Induced Liver Injury Network. Allopurinol hepatotoxicity is associated with HLA Class I Alleles that vary by Ethnicity. Liver International, 2021; 41:1884-1893. doi: 10.1111/liv.14903. PMID: 33899326 PMCID:PMC8286350
|
||
| 2021 | 77 | Ahmad J, Odin JA, Hayashi PH, Fontana RJ, Conjeevaram H, Avula B, Khan IA, Barnhart H, Vuppalanchi R, Navarro VJ; Drug-Induced Liver Injury Network. Liver injury associated with kratom, a popular opioid-like product: Experience from the U.S. drug induced liver injury network and a review of the literature. Drug Alcohol Depend. 2021 Jan 1;218:108426. doi: 10.1016/j.drugalcdep.2020.108426. PMID: 33257199. PMCID: PMC8113016
|
||
| 2021 | 76 | Hoofnagle JH, Bonkovsky HL, Phillips EJ, Ahmad J, Barnhart H, Durazo F, Fontana RJ, Gu J, Khan I, Kleiner DE, Koh C, Li Y-J, Rockey DC, Seeff LB, Serrano J, Stolz A, Tillmann HL, Vuppalanchi R, Navarro VJ. HLA-B*35:01 and Green Tea Induced Liver Injury. Hepatology. 2021 Jun;73(6):2484-2493. doi: 10.1002/hep.31538. PMID: 32892374 PMCID: PMC8052949
|
||
| 2021 | 75 | Kim HP, Navarro V, Zacks S, Odin J, Kleiner DE, Hayashi PH. The Clinical Spectrum and Diagnosis of Oxaliplatin Liver Injury in the Era of Non-alcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2021 Oct;19(10):2199-2201. doi: 10.1016/j.cgh.2020.09.038. PMID: 33007507 PMCID: PMC8007645.
|
||
| 2021 | 74 | Li YJ, Phillips E, Dellinger A, Nicoletti P, Schutte R, Li, D, Ostrov DA, Fontana RJ, Watkins PB, Stolz A, Daly AK, Aithal GP, Barnhart H, Chalasani N. HLA‐B*14:01 and HLA‐B*35:01 are associated with trimethoprim‐sulfamethoxazole induced liver injury. Hepatology. 2021 Jan;73(1):268-281. doi: 10.1002/hep.31258. PMID: 32270503 PMCID: PMC7544638
|
||
| 2020 | 73 | Lammert C, Zhu C, Lian Y, Ramani I, Eckert G, Li Q-Z, Chalasani N. An Exploratory Study of Autoantibody Profiling in Drug Induced Liver Injury with Autoimmune Phenotype. Hepatol Commun. 2020 Nov; 4(11): 1651–1663. PMID: 33163835 PMCID: PMC7603536
|
||
| 2020 | 72 | Ghabril M, Gu J, Yoder L, Corbito L, Dakhoul L, Ringel A, Beyer CD, Vuppalanchi R, Barnhart H, Hayashi PH, Chalasani N. Significant Medical Comorbidities Are Associated With Lower Causality Scores in Patients Presenting With Suspected Drug-Induced Liver Injury. Clin Transl Gastroenterol. 2020 Apr;11(4):e00141. doi: 10.14309/ctg.0000000000000141. PMID: 32251016 PMCID: PMC7263658
|
||
| 2020 | 71 | Bjornsson HK, Bjornsson ES, Avula B, Khan IA, Jonasson JG, Ghabril M, Hayashi PH, Navarro V. Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network. Liver Int. 2020 Apr;40(4):825-829. doi: 10.1111/liv.14393. PMID:31991029 PMCID: PMC8041491
|
||
| 2019 | 70 | Kamal N, Koh C, Samala N, Fontana R, Stolz A, Durazo F, Hayashi PH, Phillips E, Wang T, Hoofnagle JH. Asparaginase-induced Hepatotoxicity: Rapid Development of Cholestasis and Hepatic Steatosis. Hepatol Int. 2019 Sep;13(5):641-648. doi: 10.1007/s12072-019-09971-2. PMID: 31392570 PMCID: PMC7226930
|
||
| 2019 | 69 | Ghabril M, Gu J, Yoder L, Corbito L, Ringel A, Beyer CD, Vuppalanchi R, Barnhart H, Hayashi PH, Chalasani N. Development and Validation of Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 months for Patients With Suspected Drug-Induced Liver Injury. Gastroenterology. 2019 Nov; 157(5): 1245-1252. doi: 10.1053/j.gastro.2019.07.006. PMID: 31302142 PMCID: PMC6815697
|
||
| 2019 | 68 | Bonkovsky HL, Severson T, Nicoletti P, Barnhart H, Serrano J, Chalasani N, Fontana RJ, Watkins PB, Navarro V, Stolz A, Daly A, Aithal GP, Odin J. Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug-Induced Liver Injury. Hepatol Commun. 2019 Jun 6;3(8):1032-1035. doi: 10.1002/hep4.1382. PMID: 31388624 PMCID: PMC6671782
|
||
| 2019 | 67 | Dipaola F, Molleston JP, Gu J, Cirulli ET, Chalasani N, Barnhart H, Kleiner DE, Hoofnagle JH, Fontana RJ, on behalf of the US Drug Induced Livery Injury Network. Antimicrobials and anti-epileptics are the leading causes of Idiosyncratic Drug Induced Liver Injury in Children. Journal of Pediatric Gastroenterology & Nutrition. 2019 Aug;69(2):152-159. doi: 10.1097/MPG.0000000000002383. PMID: 31169665 PMCID: PMC6658343
|
||
| 2019 | 66 | Stolz A, Navarro V, Hayashi PH, Fontana RJ, Barnhart HX, Gu J, Chalasani NP, Vega MM, Bonkovsky HL, Seeff LB, Serrano J, Avula B, Khan IA, Cirulli ET, Kleiner DE, Hoofnagle JH; DILIN Investigators. Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors. Aliment Pharmacol Ther. 2019 May;49(9):1195-1204. doi: 10.1111/apt.15211. PMID: 30934130 PMCID: PMC6682544
|
||
| 2019 | 65 | Navarro V, Avula B, Khan I, Verma M, Seeff L, Serrano J, Fontana R, Ahmad J, Stolz A, for the Drug Induced Liver Injury Network Investigators. The Contents of Herbal and Dietary Supplements Implicated in Liver Injury in the United States are Frequently Mislabeled. Hepatol Commun. 2019 Apr 3;3(6):792-794. doi: 10.1002/hep4.1346. PMID: 31168513 PMCID: PMC6545864
|
||
| 2019 | 64 | Ahmad, J., Reddy, KR, Tillmann, HL, Hayashi PH, Chalasani N, Fontana RJ, Navarro VJ, Stolz A, Barnhart H, Cloherty GA, Hoofnagle JH. Importance of Hepatitis C Virus RNA Testing in Patients with Suspected Drug-Induced Liver Injury. Dig Dis Sci. 2019 Sep;64(9):2645-2652. doi: 10.1007/s10620-019-05591-w. PMID: 30927209 PMCID: PMC6706305
|
||
| 2019 | 63 | Cirulli ET, Nicoletti P, Abramson K, Andrade RJ, Bjornsson ES, Chalasani N, Fontana RJ, Hallberg P, Li YJ, Lucena MI, Long N, Molokhia M, Nelson MR, Odin JA, Pirmohamed M, Rafnar T, Serrano J, Stefansson K, Stolz A, Daly AK, Aithal GP, Watkins PB; on behalf of Drug-Induced Liver Injury Network (DILIN) investigators and International DILI consortium (iDILIC). A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury. Gastroenterology. 2019 May;156(6):1707-1716.e2. doi: 10.1053/j.gastro.2019.01.034. PMID: 30664875 PMCID: PMC6511989
|
||
| 2019 | 62 | Church RJ, Kullak-Ublick GA, Aubrecht J, Bonkovsky HL, Chalasani N, Fontana RJ, Goepfert JC, Hackman F, King NMP, Kirby S, Kirby P, Marcinak J, Ormarsdottir S, Schomaker SJ, Schuppe-Koistinen I, Wolenski F, Arber N, Merz M, Sauer JM, Andrade RJ, van Bömmel F, Poynard T, Watkins PB. Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort. Hepatology. 2019 Feb;69(2):760-773. doi: 10.1002/hep.29802. PMID: 29357190; PubMed Central PMCID: PMC6054900.
|
||
| 2019 | 61 | Ahmad J, Rossi S, Rodgers SK, Ghabril M, Fontana RJ, Stolz A, Hayashi PH, Barnhart H, Kleiner DE, Bjornsson ES. Sclerosing Cholangitis-Like Changes on Magnetic Resonance Cholangiography in Patients With Drug Induced Liver Injury. Clin Gastroenterol Hepatol. 2019 Mar;17(4):789-790. doi: 10.1016/j.cgh.2018.06.035. PubMed PMID: 29966706. PubMed PMCID: PMC6311440.
|
||
| 2018 | 60 | Bonkovsky H, Barnhart H, Foureau D, Steuerwald N, Lee W, Gu J, Fontana R, Hayashi P, Chalasani N, Navarro V, Odin J, Stolz A, Watkins P, Serrano J. Cytokine Profiles in Acute Liver Injury—Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group. PLoS One. 2018 Oct 25;13(10):e0206389. doi: 10.1371/journal.pone.0206389. eCollection 2018. PubMed PMID: 30359443. PubMed PMCID: PMC6201986.
|
||
| 2018 | 59 | Fontana RJ, Cirulli ET, Gu J, Kleiner D, Ostrov D, Phillips E, Schutte R, Barnhart H, Chalasani N, Watkins PB, Hoofnagle JH. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine. J Hepatol. 2018 Dec;69(6):1317-1325. doi: 10.1016/j.jhep.2018.08.004. PMID: 30138689 PMCID: PMC6472700
|
||
| 2018 | 58 | Kowalec K, Wright GEB, Drögemöller B, Aminkeng F, Bhavsar AP, Kingwell E, Yoshida EM, Traboulsee A, Marrie RN, Kremenchutzky M, Campbell TL, Duquette P, Chalasani N, Wadelius M, Hallberg P, Xia Z, De Jager PL, Denny JC, Davis MF, Ross CJD, Tremlett H, and Carleton BC. Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis; Nat Genet. 2018 Aug;50(8):1081-1085. doi: 10.1038/s41588-018-0168-y. PMID: 30013178 PMCID: PMC6513312
|
||
| 2018 | 57 | Dakhoul L, Ghabril M, Gu J, Navarro V, Chalasani N, Serrano J, for the United States Drug Induced Liver Injury Network. Heavy Consumption of Alcohol is Not Associated With Worse Outcomes in Patients With Idiosyncratic Drug-induced Liver Injury Compared to Non-Drinkers. Clinical Gastroenterology and Hepatology, 2018; 16:722-729. PubMed PMID: 29306044. PubMed Central PMCID: PMC5911195.
|
||
| 2017 | 56 | Ahmad J, Odin JA, Hayashi PH, Chalasani N, Fontana RJ, Barnhart H, Cirulli ET, Kleiner DE, Hoofnagle JH. Identification and Characterization of Fenofibrate-Induced Liver Injury. Dig Dis Sci. 2017; 62: 3596-3604. https://doi.org/10.1007/s10620-017-4812-7. PubMed PMID: 29119413; PubMed PMCID: PMC5694705
|
||
| 2017 | 55 | Vega M, Verma M, Beswick D, Bey S, Hossack J, Merriman N, Shah A, Navarro V, Drug Induced Liver Injury Network (DILIN). The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware. Drug Saf (2017) 40: 783-787. doi: 10.1007/s40264-017-0547-9. PubMed PMID: 28555362. PubMed Central PMCID: PMC5699929
|
||
| 2017 | 54 | Hayashi PH, Rockey DC, Fontana RJ, Tillmann HL, Kaplowitz N, Barnhart HX, Gu J, Chalasani NP, Reddy KR, Sherker AH, Hoofnagle JH; Drug-Induced Liver Injury Network (DILIN) Investigators. Death and liver transplantation within 2 years of onset of drug-induced liver injury. Hepatology. 2017 Oct;66(4):1275-1285. PubMed PMID: 28543844. PubMed Central PMCID: PMC5605419
|
||
| 2017 | 53 | Chalasani N, Reddy KRK, Fontana RJ, Barnhart H, Gu J, Hayashi PH, Ahmad J, Stolz A, Navarro V, Hoofnagle JH. Idiosyncratic Drug Induced Liver Injury in African-Americans Is Associated With Greater Morbidity and Mortality Compared to Caucasians. Am J Gastroenterol. 2017 Sep;112(9):1382-1388. doi: 10.1038/ajg.2017.215. PubMed PMID: 28762375. Central PMCID: PMC5667647
|
||
| 2017 | 52 | Urban TJ, Nicoletti P, Chalasani N, Serrano J, Stolz A, Daly A, Aithal G, Dillon J, Navarro V, Odin J, Barnhart H, Ostrov D, Long N, Cirulli ET, Watkins PB, Fontana RJ, on behalf of the Drug-Induced Liver Injury Network (DILIN), the Pharmacogenetics of Drug-Induced Liver Injury group (DILIGEN) and the International Serious Adverse Events Consortium (iSAEC). Minocycline Hepatotoxicity: Clinical characterization and identification of HLA-B* 35:02 as a risk factor. J Hepatol. 2017 Jul;67(1):137-144. doi: 10.1016/j.jhep.2017.03.010. PubMed PMID: 28323125. PubMed Central PMCID: PMC5634615
|
||
| 2017 | 51 | Suzuki A, Barnhart H, Gu J, Bonkovsky HL, Tillmann HL, Fontana RJ, Kleiner DE, for Drug-induced Liver Injury Network (DILIN). Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury. Liver International. 2017; 37(11):1723-1730. doi: 10.1111/liv.13380. PubMed PMID: 28161910. Central PMCID: PMC5545077
|
||
| 2017 | 50 | Navarro VJ, Khan I, Björnsson E, Seeff LB, Serrano J, and Hoofnagle JH. Liver Injury From Herbal and Dietary Supplements. Hepatology. 2017 Jan;65(1):363-373. doi: 10.1002/hep.28813. PubMed PMID: 217981596; PubMed Central PMCID:PMC5502701
|
||
| 2017 | 49 | Nicoletti P, Aithal GP, Bjornsson ES, Andrade RJ, Sawle A, Arrese M, Barnhart HX, Bondon-Guitton E, Hayashi PH, Bessone F, Carvajal A, Cascorbi I, Cirulli ET, Chalasani N, Conforti A, Coulthard SA, Daly MJ, Day CP, Dillon JF, Fontana RJ, Grove JI, Hallberg P, Hernández N, Ibáñez L, Kullak-Ublick GA, Laitinen T, Larrey D, Lucena MI, Maitland-van der Zee AH, Martin JH, Molokhia M, Pirmohamed M, Powell EE, Qin S, Serrano J, Stephens C, Stolz A, Wadelius M, Watkins PB, Floratos A, Shen Y, Nelson MR, Urban TJ, Daly AK; International Drug-Induced Liver Injury Consortium, Drug-Induced Liver Injury Network Investigators, and International Serious Adverse Events Consortium. Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study. Gastroenterology. 2017 Apr;152(5):1078-1089. doi: 10.1053/j.gastro.2016.12.016. PubMed PMID: 28043905. Central PMCID: PMC5367948
|
||
| 2017 | 48 | Bonkovsky HL, Kleiner DE, Gu J, Odin JA, Russo MW, Navarro VM, Fontana RJ, Ghabril MS, Barnhart H, Hoofnagle JH, for the US Drug-Induced Liver Injury Network Investigators. Clinical presentations and outcomes of bile duct loss caused by drugs and herbals and dietary supplements. Hepatology 2017 Apr;65(4):1267-1277. Doi: 10.1002/hep.28967. PubMed PMID: 217981596; PubMed Central PMCID: PMC5360519.
|
||
| 2017 | 47 | Russo MW, Steuerwald N, Norton HJ, Anderson WE, Foureau D, Chalasani N, Fontana RJ, Watkins P, Serrano J, Bonkovsky HL. Profiles of miRNAs in Serum in Severe Acute Drug Induced Liver Injury and their Prognostic Significance. Liver Int. 2017 May;37(5):757-764. doi: 10.1111/liv.13312. PubMed PMID: 27860186; PubMed Central PMCID: PMC5502673
|
||
| 2017 | 46 | Whritenour J, Ko M, Zong Q, Wang J, Tartaro K, Schneider P, Olson E, VanVolkenburg M, Gu J, Serrano J, Hayashi P, Fontana R, Chalasani N, Bonkovsky HL. Development of a Modified Lymphocyte Transformation Test for Diagnosing Drug Induced Liver Injury Associated with an Adaptive Immune Response. Journal of Immunotoxicology, 2017; 14(1): 31-28. DOI: 10.1080/1547691X.2016.1254305. PubMed PMID: 28121193; PubMed Central PMCID: PMC5505862
|
||
| 2017 | 45 | de Boer YS, Kosinski AS, Urban TJ, Zhao Z, Long N, Chalasani N, Kleiner DE, and Hoofnagle JH for the Drug-Induced Liver Injury Network. Features of Autoimmune Hepatitis in Patients with Drug-induced Liver Injury. Clin Gastroenterol Hepatol. 2017 Jan;15(1):103-112. doi: 10.1016/j.cgh.2016.05.043. PubMed PMID: 27311619; PubMed Central PMCID: PMC5370577.
|
||
| 2017 | 44 | Björnsson ES, Gu J, Kleiner DE, Chalasani N, Hayashi PH, Hoofnagle JH for the DILIN Investigators. Azathioprine and 6-Mercaptopurine Induced Liver Injury: Clinical Features and Outcomes. J Clin Gastroenterol. 2017 Jan;51(1):63-69. PubMed PMID: 27648552; PubMed Central PMCID:PMC5505863
|
||
| 2016 | 43 | Zheng EX, Rossi S, Fontana RJ, Vuppalanchi R, Hoofnagle JH, Khan I, and Navarro VJ for the Drug Induced Liver Injury Network (DILIN). Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK Weight Loss Products: Results from the DILIN Prospective Study. Drug Saf. 2016 Aug;39(8):749-54. doi: 10.1007/s40264-016-0428-7. PubMed PMID: 27189593; PubMed Central PMCID: PMC4961850.
|
||
| 2016 | 42 | Heidemann LA, Navarro VJ, Ahmad, J, Hayashi PH, Stolz A, Kleiner DE, Fontana RJ on behalf of the DILIN Investigators. Severe Acute Hepatocellular Injury Attributed to OxyELITE Pro: A Case Series. Dig Dis Sci. 2016 Sep;61(9):2741-8. doi: 10.1007/s10620-016-4181-7. PubMed PMID: 27142670; PubMed Central PMCID: PMC4982804.
|
||
| 2016 | 41 | deLemos AS, Ghabril M, Rockey DC, Gu J, Barnhart HX, Fontana RJ, Kleiner DE, and Bonkovsky HL for the DILIN study investigators. Amoxicillin-Clavulanate Induced Liver Injury. Digestive Diseases and Sciences; Digestive Disease and Sciences 2016 Aug;61(8):2406-16. doi:10.1007/s10620-016-4121-6. PubMed PMID: 27003146; PubMed Central PMCID:PMC4945382
|
||
| 2016 | 40 | Schmeltzer PA, Kosinski AS, Kleiner DE, Hoofnagle JH, Stolz A, Fontana RJ, Russo MW, MD for the Drug-Induced Liver Injury Network (DILIN). Liver Injury from Nonsteroidal Anti-inflammatory Drugs in the United States. Liver Int. 2016 Apr;36(4):603-9. doi: 10.1111/liv.13032. PubMed PMID: 26601797; PubMed Central PMCID:PMC5035108
|
||
| 2016 | 39 | Bohm M, Vuppalanchi R, Chalasani N, and the Drug Induced Liver Injury Network (DILIN). Febuxostat-Induced Acute Liver Injury. Hepatology, 2016 Mar;63(3):1047-9. doi: 10.1002/hep.28403. PubMed PMID: 26679098; PubMed Central PMCID: PMC4764455
|
||
| 2015 | 38 | Fontana RJ, Hayashi PH, Barnhart H, Kleiner DE, Reddy KR, Chalasani N, Lee WM, Stolz A, Phillips 3, Serrano J, Watkins PB and DILIN Investigators. Persistent Liver Biochemistry abnormalities are more common in older patients and those with Cholestatic Drug induced Liver Injury. Am J Gastroenterol 2015; 110:1450–1459; doi: 10.1038/ajg.2015.283. PubMed PMID:26346867; PubMed Central PMCID: PMC4784423.
|
||
| 2015 | 37 | Usachov V, Urban TJ, Fontana RJ, Gross A, Lyer S, Omary MB, Strnad P. Prevalence of genetic variants of keratins 8 and 18 in patients with drug-induced liver injury. BMC Medicine (2015) 13:196 DOI 10.1186/s12916-015-0418-0. PubMed PMID:26286715; PubMed Central PMCID:PMC4545365
|
||
| 2015 | 36 | Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, Watkins PB, Navarro V, Barnhart H, Gu J, Serrano J; United States Drug Induced Liver Injury Network. Features and Outcomes of 889 Patients with Drug-induced Liver Injury: The DILIN Prospective Study. Gastroenterology. 2015 Jun;148(7):1340-52. doi: 10.1053/j.gastro.2015.03.006. PubMed PMID: 25754159; PubMed Central PMCID:PMC4446235
|
||
| 2015 | 35 | Hayashi PH, Fontana RJ, Chalasani NP, Stolz AA, Talwalker JA, Navarro VJ, Lee WM, Davern TJ, Kleiner DE, Gu J, Hoofnagle JH; U.S. DILIN Investigators. Under-reporting and Poor Adherence to Monitoring Guidelines for Severe Cases of Isoniazid Hepatotoxicity. Clin Gastroenterol Hepatol. 2015 Sep;13(9):1676-82. doi: 10.1016/j.cgh.2015.02.024. PubMed PMID: 25724701; PubMed Central PMCID: PMC4653068
|
||
| 2015 | 34 | Alqahtani SA, Kleiner DE, Ghabril M, Gu J, Hoofnagle JH, Rockey DC; Drug-Induced Liver Injury Network Study Investigators. Identification and Characterization of Cefazolin-Induced Liver Injury. Clinical Gastroenterology and Hepatology, 2015 Jul;13(7):1328-1336. doi:10.1016/j.cgh.2014.11.036. PMID: 25528012; PubMed Central PMCID:PMC4472636
|
||
| 2015 | 33 | Martinez MA, Vuppalanchi R, Fontana RJ, Stolz A, Kleiner DE, Hayashi PH, Gu J, Hoofnagle JH, Chalasani N. Clinical and histologic features of azithromycin-induced liver injury. Clin Gastroenterol Hepatol 2015 Feb; 13(2): 369-376. PMID: 25111234; PubMed Central PMCID: PMC4321982.
|
||
| 2015 | 32 | Vuppalanchi R, Navarro V, Vega M, Bonkovsky HL, Seeff L, Serrano J; Drug-Induced Liver Injury Network (DILIN). Herbal dietary supplement associated hepatotoxicity: an upcoming workshop and need for research. Gastroenterology. 2015 Mar;148(3):480-2. doi: 10.1053/j.gastro.2015.01.004. PubMed PMID: 25579757; PubMed Central PMCID: PMC4653067
|
||
| 2015 | 31 | Foureau DM, Walling TL, Maddukuri V, Anderson W, Kleiner DE, Ahrens WA, Jacobs C, McKillop IH, Watkins P, Fontana RJ, Chalasani N, Talwalkar J, Lee WM, Reddy R, Stolz A, Serrano J and Bonkovsky HL. Comparative analysis of portal hepatic infiltrating leukocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis. Clinical Experimental Immunology, 2015 Apr;180(1):40-51. doi: 10.1111/cei.12558. PubMed PMID:25418487; PubMed Central PMCID:PMC4367092
|
||
| 2015 | 30 | Church RJ, Gatti DM, Urban TJ, Long N, Yang X, Shi Q, Eaddy JS, Mosedale M, Ballard S, Churchill GA, Navarro V, Watkins PB, Threadgill DW, Harrill AH. Sensitivity to Hepatotoxicity due to Epigallocatechin Gallate is Affected by Genetic Background in Diversity Outbred Mice. Food and Chemical Toxicology. 2015 Feb;76:19-26. doi: 10.1016/j.fct.2014.11.008. PubMed PMID: 25446466; PubMed Central PMCID: PMC4324012.
|
||
| 2015 | 29 | Hayashi PH, Barnhart HX, Fontana RJ, Chalasani N, Davern TJ, Talwalkar JA, Reddy KR, Stolz AA, Hoofnagle JH, Rockey DC. Reliability of Causality Assessment for Drug, Herbal and Dietary Supplement Hepatoxicity in the Drug-Induced Liver Injury Network (DILIN). Liver Int. 2015 May;35(5):1623-32. doi: 10.1111/liv.12540. PubMed PMID: 24661785; PubMed Central PMCID: PMC4305346
|
||
| 2014 | 28 | Navarro VJ, Barnhart H, Bonkovsky HL, Davern T, Fontana RJ, Grant L, Reddy KR, Seeff LB, Serrano J, Sherker AH, Stolz A, Talwalkar J, Vega M, Vuppalanchi R. Liver Injury From Herbals and Dietary Supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology. 2014; 60: 1399–1408. doi: 10.1002/hep.27317. PubMed PMID: 25043597; PubMed Central PMCID: PMC4293199
|
||
| 2014 | 27 | Russo MW, Hoofnagle JH, Gu J, Fontana RJ, Barnhart H, Kleiner DE, Chalasani N, Bonkovsky HL. The spectrum of statin hepatotoxicity: Experience of the drug induced liver injury network. Hepatology. 2014 Aug;60(2):679-86. doi: 10.1002/hep.27157. PubMed PMID: 24700436; PubMed Central PMCID:PMC4110177
|
||
| 2014 | 26 | Fontana RJ, Hayashi PH, Gu J, Reddy KR, Barnhart H, Watkins PB, Serrano J, Lee WM, Chalasani N, Stolz A, Davern T, Talwakar JA. Idiosyncratic Drug Induced Liver Injury is associated with Substantial Morbidity and Mortality within 6 months From Onset. Gastroenterology. 2014 Jul;147(1):96-108. pii: S0016-5085(14)00429-6. doi: 10.1053/j.gastro.2014.03.045. PubMed PMID: 24681128; PubMed Central PMCID: PMC4285559
|
||
| 2014 | 25 | Vuppalanchi R, Gotur R, Reddy KR, Fontana RJ, Ghabril M, Kosinski AS, Gu J, Serrano J, Chalasani N. Relationship Between Characteristics of Medications and Drug-Induced Liver Disease Phenotype and Outcome. Clinical Gastroenterology and Hepatology 2014 Sep;12(9):1550-5. doi: 10.1016/j.cgh.2013.12.016. PubMed PMID: 24362054; PubMed Central PMCID:PMC4065228
|
||
| 2014 | 24 | Kleiner DE, Chalasani NP, Lee WM, Fontana RJ, Bonkovsky HL, Watkins PB, Hayashi PH, Davern TJ, Navarro V, Reddy R, Talwalkar JA, Stolz A, Gu J, Barnhart H, Hoofnagle JH; Drug-Induced Liver Injury Network (DILIN). Hepatic histological findings in suspected drug-induced liver injury: Systematic evaluation and clinical associations. Hepatology. 2014 Feb;59(2):661-70. doi: 10.1002/hep.26709. PubMed PMID: 24037963; PubMed Central PMCID: PMC3946736.
|
||
| 2013 | 23 | Steuerwald NM, Foureau DM, Norton HJ, Zhou J, Parsons JC, Chalasani N, Fontana RJ, Watkins PB, Lee WM, Reddy KR, Stolz A, Talwalkar J, Davern T, Saha D, Bell LN, Barnhart H, Gu J, Serrano J, Bonkovsky HL. Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance. PLoS One. 2013 Dec 27;8(12):e81974. doi: 10.1371/journal.pone.0081974. PubMed PMID: 24386086; PubMed Central PMCID: PMC3873930.
|
||
| 2013 | 22 | Navarro VJ, Bonkovsky HL, Hwang SI, Vega M, Barnhart H, Serrano J. Catechins in dietary supplements and hepatotoxicity. Dig Dis Sci. 2013 Sep;58(9):2682-90. doi: 10.1007/s10620-013-2687-9. PubMed PMID: 23625293; PubMed Central PMCID: PMC3769469.
|
||
| 2013 | 21 | Ghabril M, Bonkovsky HL, Kum C, Davern T, Hayashi PH, Kleiner DE, Serrano J, Rochon J, Fontana RJ, Bonacini M; US Drug-Induced Liver Injury Network. Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases. Clin Gastroenterology & Hepatology. 2013 May; 11(5):558-564.e3. Doi: 10.1016/j.cgh.2012.12.025. PubMed PMID: 23333219; PubMed Central PMCID: PMC3865702.
|
||
| 2013 | 20 | Ghabril M, Fontana R, Rockey D, Jiezhun G, Chalasani N. Drug-induced liver injury caused by intravenously administered medications: the Drug-induced Liver Injury Network experience. J Clin Gastroenterol. 2013 Jul; 47(6):553-8. Doi: 10.1097/MCG.0b013e318276bf00. PubMed PMID: 23388845; PubMed Central PMCID: PMC3681898.
|
||
| 2013 | 19 | Fontana RJ, Hayashi P, Bonkovsky HL, Kleiner DE, Kochhar S, Gu J, Ghabril M. Presentation and outcomes with clinically apparent interferon beta hepatotoxicity. Dig Dis Sci. 2013 Jun; 58(6):1766-75. Doi: 10.1007/s10620-012-2553-1. PubMed PMID: 23377559; PubMed Central PMCID: PMC3674196.
|
||
| 2013 | 18 | Grant LM, Kleiner DE, Conjeevaram HS, Vuppalanchi R, Lee WM. Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide. Dig Dis Sci. 2013 May; 58(5):1415-21. doi: 10.1007/s10620-012-2493-9. Review. PubMed PMID: 23212393. PubMed Central PMCID: PMC3826911
|
||
| 2012 | 17 | Urban TJ, Shen Y, Stolz A, Chalasani N, Fontana RJ, Rochon J, Ge D, Shianna KV, Daly AK, Lucena MI, Nelson MR, Molokhia M, Aithal GP, Floratos A, Pe’er I, Serrano J, Bonkovsky H, Davern TJ, Lee WM, Navarro VJ, Talwalkar JA, Goldstein DB, Watkins PB; Drug-Induced Liver Injury Network; DILIGEN; EUDRAGENE; Spanish DILI Registry; International Serious Adverse Events Consortium. Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs. Pharmacogenet Genomics. 2012 Nov; 22(11):784-95. Doi: 10.1097/FPC.0b013e3283589a76. PubMed PMID: 22968431; PubMed Central PMCID: PMC3636716.
|
||
| 2012 | 16 | Urban TJ, Goldstein DB, Watkins PB. Genetic basis of susceptibility to drug-induced liver injury: what have we learned and where do we go from here? Pharmacogenomics. 2012 May; 13(7):735-8. Doi: 10.2217/pgs.12.45. PubMed PMID: 22594502; PubMed Central PMCID: PMC3641893.
|
||
| 2012 | 15 | Chalasani N, Vuppalanchi R, Navarro V, Fontana R, Bonkovsky H, Barnhart H, Kleiner DE, Hoofnagle JH. Acute liver injury due to flavocoxid (Limbrel), a medical food for osteoarthritis: a case series. Ann Intern Med. 2012 Jun 19; 156(12):857-60, W297-300. doi: 10.7326/0003-4819-156-12-201206190-00006. PubMed PMID: 22711078. PubMed Central PMCID: PMC3825458
|
||
| 2012 | 14 | Bell LN, Vuppalanchi R, Watkins PB, Bonkovsky HL, Serrano J, Fontana RJ, Wang M, Rochon J, Chalasani N; US Drug-Induced Liver Injury Network (DILIN) Research Group. Serum proteomic profiling in patients with drug-induced liver injury. Aliment Pharmacol Ther. 2012 Mar; 35(5):600-12. PubMed PMID: 22403816; PubMed Central PMCID: PMC3654532.
|
||
| 2011 | 13 | Davern TJ, Chalasani N, Fontana RJ, Hayashi PH, Protiva P, Kleiner DE, Engle RE, Nguyen H, Emerson SU, Purcell RH, Tillmann HL, Gu J, Serrano J, Hoofnagle JH; Drug-Induced Liver Injury Network (DILIN). Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology. 2011 Nov; 141(5):1665-72.e1-9. Doi: 10.1053/j.gastro.2011.07.051. PubMed PMID: 21855518; PubMed Central PMCID: PMC3654540.
|
||
| 2011 | 12 | Molleston JP, Fontana RJ, Lopez MJ, Kleiner DE, Gu J, Chalasani N; Drug-Induced Liver Injury Network. Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study. J Pediatr Gastroenterol Nutr. 2011 Aug; 53(2):182-9. Doi: 10.1097/MPG.0b013e31821d6cfd. PubMed PMID: 21788760; PubMed Central PMCID: PMC3634369.
|
||
| 2011 | 11 | Lucena MI, Molokhia M, Shen Y, Urban TJ, Aithal GP, Andrade RJ, Day CP, Ruiz-Cabello F, Donaldson PT, Stephens C, Pirmohamed M, Romero-Gomez M, Navarro JM, Fontana RJ, Miller M, Groome M, Bondon-Guitton E, Conforti A, Stricker BH, Carvajal A, Ibanez L, Yue QY, Eichelbaum M, Floratos A, Pe’er I, Daly MJ, Goldstein DB, Dillon JF, Nelson MR, Watkins PB, Daly AK; Spanish DILI Registry; EUDRAGENE; DILIN; DILIGEN; International SAEC. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology. 2011 Jul; 141(1):338-47. doi: 10.1053/j.gastro.2011.04.001. PubMed PMID: 21570397; PubMed Central PMCID: | ||
| 2011 | 10 | Orman ES, Conjeevaram HS, Vuppalanchi R, Freston JW, Rochon J, Kleiner DE, Hayashi PH; DILIN Research Group. Clinical and histopathologic features of fluoroquinolone-induced liver injury. Clinical Gastroenterology & Hepatology. 2011 Jun; 9(6):517-523.e3. doi: 10.1016/j.cgh.2011.02.019. PubMed PMID: 21356330; PubMed Central PMCID: PMC3718017.
|
||
| 2010 | 9 | Vuppalanchi R, Hayashi PH, Chalasani N, Fontana RJ, Bonkovsky H, Saxena R, Kleiner D, Hoofnagle JH; Drug-Induced Liver Injury Network (DILIN). Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network. Aliment Pharmacol Ther. 2010 Nov; 32(9):1174-83. Doi: 10.1111/j.1365-2036.2010.04449.x. PubMed PMID: 20815829. PubMed Central PMCID: PMC3773985
|
||
| 2010 | 8 | Fong TL, Klontz KC, Canas-Coto A, Casper SJ, Durazo FA, Davern TJ 2nd, Hayashi P, Lee WM, Seeff LB. Hepatotoxicity due to hydroxycut: a case series. Am J Gastroenterol. 2010 Jul; 105(7):1561-6. Doi: 10.1038/ajg.2010.5. PubMed PMID: 20104221. PubMed Central PMCID: PMC3825455
|
||
| 2010 | 7 | Rockey DC, Seeff LB, Rochon J, Freston J, Chalasani N, Bonacini M, Fontana RJ, Hayashi PH; US Drug-Induced Liver Injury Network. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology. 2010 Jun; 51(6):2117-26. Doi: 10.1002/hep.23577. PubMed PMID: 20512999; PubMed Central PMCID: PMC3249230.
|
||
| 2010 | 6 | Agarwal VK, McHutchison JG, Hoofnagle JH; Drug-Induced Liver Injury Network. Important elements for the diagnosis of drug-induced liver injury. Clin Gastroenterol Hepatol. 2010 May; 8(5):463-70. Doi: 10.1016/j.cgh.2010.02.008. Review. PubMed PMID: 20170750. PMCID: PMC3901223
|
||
| 2010 | 5 | Fontana RJ, Seeff LB, Andrade RJ, Björnsson E, Day CP, Serrano J, Hoofnagle JH. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology. 2010 Aug; 52(2):730-42. Doi: 10.1002/hep.23696. PubMed PMID: 20564754; PubMed Central PMCID: PMC3616501.
|
||
| 2010 | 4 | Stewart JD, Horvath R, Baruffini E, Ferrero I, Bulst S, Watkins PB, Fontana RJ, Day CP, Chinnery PF. Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicity. Hepatology. 2010 Nov; 52(5):1791-6. Doi: 10.1002/hep.23891. PubMed PMID: 21038416; PubMed Central PMCID:PMC3841971.
|
||
| 2009 | 3 | Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, Rochon J; DILIN Study Group. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Safety. 2009; 32(1):55-68. doi: 10.2165/00002018-200932010-00005. PubMed PMID: 19132805; PubMed Central PMCID: PMC3637941.
|
||
| 2008 | 2 | Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J; Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 2008 Dec; 135(6):1924-34, 1934.e1-4. Doi: 10.1053/j.gastro.2008.09.011. PubMed PMID: 18955056; PubMed Central PMCID: PMC3654244.
|
||
| 2008 | 1 | Rochon J, Protiva P, Seeff LB, Fontana RJ, Liangpunsakul S, Watkins PB, Davern T, McHutchison JG; Drug-Induced Liver Injury Network (DILIN). Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury. Hepatology. 2008 Oct; 48(4):1175-83. Doi: 10.1002/hep.22442. PubMed PMID: 18798340; PubMed Central PMCID: PMC3618289.
|